Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.-Reference-Cited by-同舟云学术

Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.

Published:1987-02-01 Issue:2 Volume:71 Page:78-85
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:British Journal of Ophthalmology

Author:

Dadzie K Y,Bird A C,Awadzi K,Schulz-Key H,Gilles H M,Aziz M A

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference32 articles.

1. Ocular manifestations in onchocerciasis;Weyts, E.J.;Doc Med Geogr,1956

2. Comparison of the effect upon onchocerciasis of five drugs and selection of the one best able to prevent ocular complications;Rodger, F.C.;Trans R Soc Trop Med Hyg,1958

3. Les complications oculaires de l'onchocercose: problem du prognostic visuel chez les sujets traits;Quere, M.A.; Lariviere, M.; Razafinato, R.;Bull Soc Med Afr Noire Fr,1965

4. Les difficulties therapeutiques de l'onchocercose oculaire;Toufic, N.;Arch Ophthalmol (Paris)

5. A propos d'une papillite onchocerquienne;Vedy, J.; Sirol, J.;Med Trop (Mars),1971

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia;Parasites & Vectors;2024-03-15

2. Man With Disappearing Subconjunctival Foreign Body;JAMA Ophthalmology;2023-10-01

3. A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis;PLOS Neglected Tropical Diseases;2023-05-19

4. O. volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: Results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia;2023-05-04

5. A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana;The American Journal of Tropical Medicine and Hygiene;2022-02-02